About Molecular Pathways

Molecular Pathways (a division of CliniSense Corporation) was founded in 2001 by Stephen E. Zweig, Ph.D. 

Dr. Zweig has over twenty years experience in biotechnology.  Before starting CliniSense, he founded Avocet Medical, Inc. in 1991, and served as CEO through 1997, and Chairman through 2001.  Avocet developed the AvoSureTM home CoumadinTM monitoring meter, which pioneered new treatments for thrombosis in the US and Europe.  Its innovative dry-reagent protease-substrate chemistry and miniaturized fluorescent detector technology won an AAMI award in 1997.  It has since been acquired by Beckman-Coulter.

Dr. Zweig received his Ph.D. in biochemistry from UCSD in 1980.  He was an assistant professor in pharmacology at Baylor College of Medicine, and an Arthritis Foundation postdoctoral fellow at NIH.  Dr. Zweig has also held management positions at Bayer Diagnostics, and LifeScan, a Johnson and Johnson company.

Dr. Zweig is an advisor to the College of Creative Studies at UCSB.His oth

Company address:  Molecular Pathways, 15466 Los Gatos Blvd., Suite 109-355, Los Gatos, CA  95032.  Telephone: (408) 348-1495     Fax:  (408) 399-9705   Email:  admin@mpways.com

Membrane  Antigen-Antibody  Protease substrates  Electrochemical  About us  Patents  Home